Marker Therapeutics Inc

NASDAQ:MRKR   3:59:05 PM EDT
1.13
+0.07 (+6.60%)
Earnings Announcements

Marker Therapeutics Posts Quarterly Loss Per Share Of 15 Cents

Published: 11/10/2021 22:29 GMT
Marker Therapeutics Inc (MRKR) - Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results.
Marker Therapeutics Inc - Believes Cash, Equivalents Balance Will Fund Expenses and Capex Needs Into Q1 of 2023.
Marker Therapeutics Inc Qtrly Loss per Share 15 Cents.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.